These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26713839)

  • 61. [Effect of recombinant human growth hormone on glucose metabolism in children with growth hormone deficiency].
    Liang L; Zou CC; Li Y; Wang CL; Jiang YJ; Dong GP; Fu JF; Wang XM
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):657-61. PubMed ID: 17217656
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A new sustained-release preparation of human growth hormone and its pharmacokinetic, pharmacodynamic and safety profile.
    Jostel A; Mukherjee A; Alenfall J; Smethurst L; Shalet SM
    Clin Endocrinol (Oxf); 2005 May; 62(5):623-7. PubMed ID: 15853836
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method.
    Kang J; Wu F; Cai Y; Xu M; He M; Yuan W
    Eur J Pharm Sci; 2014 Oct; 62():141-7. PubMed ID: 24907681
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lack of dietary carbohydrates induces hepatic growth hormone (GH) resistance in rats.
    Bielohuby M; Sawitzky M; Stoehr BJ; Stock P; Menhofer D; Ebensing S; Bjerre M; Frystyk J; Binder G; Strasburger C; Wu Z; Christ B; Hoeflich A; Bidlingmaier M
    Endocrinology; 2011 May; 152(5):1948-60. PubMed ID: 21427215
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacokinetics and pharmacodynamics of GH: dependence on route and dosage of administration.
    Keller A; Wu Z; Kratzsch J; Keller E; Blum WF; Kniess A; Preiss R; Teichert J; Strasburger CJ; Bidlingmaier M
    Eur J Endocrinol; 2007 Jun; 156(6):647-53. PubMed ID: 17535864
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats.
    Gargosky SE; Tapanainen P; Rosenfeld RG
    Endocrinology; 1994 May; 134(5):2267-76. PubMed ID: 7512499
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hepatic growth hormone resistance during sepsis is associated with increased suppressors of cytokine signaling expression and impaired growth hormone signaling.
    Yumet G; Shumate ML; Bryant DP; Lang CH; Cooney RN
    Crit Care Med; 2006 May; 34(5):1420-7. PubMed ID: 16540952
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of China-made recombinant human growth hormone on the treatment of growth hormone deficiency.
    Jiang J; Wang W; Sun WX; Wang XM; Ni JH; Chen FS; Wang DF
    Chin Med Sci J; 2004 Sep; 19(3):225-9. PubMed ID: 15506654
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The interrelationship of growth hormone (GH), liver membrane GH receptor, serum GH-binding protein activity, and insulin-like growth factor I in the male rat.
    Bick T; Amit T; Barkey RJ; Hertz P; Youdim MB; Hochberg Z
    Endocrinology; 1990 Apr; 126(4):1914-20. PubMed ID: 2318149
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Insulin-like growth factor I (IGF-I) replacement during growth hormone receptor antagonism normalizes serum IGF-binding protein-3 and markers of bone formation in ovariectomized rhesus monkeys.
    Wilson ME
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1557-62. PubMed ID: 10770197
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Growth hormone stimulates transcription of the gene encoding the acid-labile subunit (ALS) of the circulating insulin-like growth factor-binding protein complex and ALS promoter activity in rat liver.
    Ooi GT; Cohen FJ; Tseng LY; Rechler MM; Boisclair YR
    Mol Endocrinol; 1997 Jun; 11(7):997-1007. PubMed ID: 9178759
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mammary tumorigenesis in growth hormone deficient spontaneous dwarf rats; effects of hormonal treatments.
    Thordarson G; Semaan S; Low C; Ochoa D; Leong H; Rajkumar L; Guzman RC; Nandi S; Talamantes F
    Breast Cancer Res Treat; 2004 Oct; 87(3):277-90. PubMed ID: 15528971
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade.
    Nielsen C; Gormsen LC; Jessen N; Pedersen SB; Møller N; Lund S; Jørgensen JO
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2842-50. PubMed ID: 18460563
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states.
    Fang P; Riedl S; Amselem S; Pratt KL; Little BM; Haeusler G; Hwa V; Frisch H; Rosenfeld RG
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2223-31. PubMed ID: 17405847
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human growth hormone-transferrin fusion protein for oral delivery in hypophysectomized rats.
    Amet N; Wang W; Shen WC
    J Control Release; 2010 Jan; 141(2):177-82. PubMed ID: 19761807
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G; Baur F; Schweizer R; Ranke MB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Transdermal delivery of human growth hormone through RF-microchannels.
    Levin G; Gershonowitz A; Sacks H; Stern M; Sherman A; Rudaev S; Zivin I; Phillip M
    Pharm Res; 2005 Apr; 22(4):550-5. PubMed ID: 15846462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.